ALUR | Allurion Technologies Inc. Stock Overview

(Stock Exchange: NYSE)

Day's Range	3.53 - 7.56
52 Week Range	3.53 - 98.75
Beta	0.62
Implied Volatility	446.81%
IV Rank	81.56%
Day's Volume	220,792
Average Volume	25,457
Shares Outstanding	2,711,260
Market Cap	10,357,013
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2021-03-29

Valuation
Profitability
Growth
Health
P/E Ratio	-0.37
Forward P/E Ratio	N/A
EPS	-10.25
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	501
Country	USA
Website	ALUR

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.

*Chart delayed

Analyzing fundamentals for ALUR we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see ALUR Fundamentals page.

Watching at ALUR technicals we can see that long-term trend is bearish, while middle-term trend is bullish, as well as bullish short-term trend. More technicals details can be found on ALUR Technicals page.